Unlike conventional stimulants, no anxiety, agitation and insomnia; selectively stimulates brain's adrenergic receptors for norepinephrine (noradrenaline), a neurotransmitter linked to alertness, learning, and memory.
Accounts of use for depression, ADD/ADHD, fibromyalgia, chronic fatigue (off-label). Metabolic precursor to modafinil; takes 1 hr to kick in, hard on liver. Not "controlled" like modafinil/Provigil.
depressed individuals actually have more realistic perceptions of their own image, importance, and abilities than the average person. While it’s still generally accepted that depressed people can be negatively biased in their interpretation of events an
Authorities report that more than half the population experiences trauma, which makes people more likely to develop PTSD, depression, anxiety and physical illness later in life. Now, a new study finds that among ‘healthy’ individuals, those who displa
A nonspecific immune reaction inducing a syndrome profile of fever, pain, anxiety, depression, reclusivity, anorexia, stress hormones, triggered by signals in the brain’s hypothalamus; body’s attempt to produce & preserve energy; cells secrete proinfl
Ketamine blocks a brain protein called the N-methyl-D-aspartic acid (NMDA) receptor. Previous studies have shown that agents that block the NMDA receptor reduce depression-like behaviors in animals.
This CURRENTLY ENROLLING study will test whether a single dose of ketamine - a drug that blocks a brain receptor called NMDA - can cause a rapid (next day) antidepressant effect in patients with major depression. Several medications are effective for trea
After reading Michael Fumento's article several points need to be made. In the first place, after clicking the link and reading the study itself, it bears emphasizing that the sample size-18 patients, is extremely small. This by definition makes it diffic
Dr. Zarate and colleagues said a single injection of ketamine, which targets the N-methlyl-D-aspartate (NMDA) receptor, can eliminate depression symptoms within 110 minutes.
17 depressed patients randomly assigned to receive either an injection of ketamine or a placebo. For 71% of those receiving the real deal, depression improved within a single day. Indeed, 29% became nearly free symptom free. Thirty-five percent of patient